Synthesis and biological evaluations of enoxacin carboxamide derivatives

Archives of Pharmacal Research

Volumn 32, Issue 7, 2009, Pages 967-974

  Saeed Arayne, M ^a   Sultana, Najma ^a   Haroon, Urooj ^a   Ahmed Mesaik, M ^a   Asif, Muhammad ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Antibacterial activity; Derivatives; Enoxacin; Nucleophilic substitution; Oxidative burst response

Indexed keywords

AMIDE; ANTIINFECTIVE AGENT; AROMATIC AMINE; CARBOXYLIC ACID; ENOXACIN; FUNCTIONAL GROUP;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG INHIBITION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; MOUSE; NONHUMAN; PHAGOCYTE; SPECTROSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOXACIN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; IMIDAZOLES; MACROPHAGES, PERITONEAL; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MOLECULAR STRUCTURE; NEUTROPHILS; RESPIRATORY BURST; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 68649104028     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1700-5     Document Type: Article

References (36)

1. J. R. Anacona C. Toledo 2001 Synthesis and antibacterial activity of metal complexes of ciprofloxacin Transi. Metal Chem. 26 228 231
2. V. E. Anderson N. Osheroff 2001 Type II topoisomerases as targets for quinolone antibacterials: Turning Dr. Jekyll into Mr. Hyde Curr. Pharmaceut. Design. 7 339 355
3. P. Ball A. Fernald G. Tillotson 1998 Therapeutic advances of new fluoroquinolones Expert. Opin. Invest. Drugs. 7 761 783
4. P. Ball 2000 Quinolone-induced QT interval prolongation: a notso-unexpected class effect J. Antimicrob. Chemother. 45 557 559
5. A. W. Bauer W. M. M. Kirby J. C. Sherris M. Turck 1966 Antibiotic susceptibility testing by a standard single disk method Am. J. Clin. Pathol. 45 493 496
6. J. M. Blandeau 1999 Expanded activity and utility of the new fluoroquinolones: A review Clini. Therap. 21 3 40
7. J. S. Chapman N. H. Georgopapadakou 1988 Routes of quinolone permeation in Escherichia coli Antimicrob. Chemother. 32 438 442
8. N. X. Chin H. C. Neu 1983 In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim Antimicrob. Chemother. 24 754 763
9. D. T. W. Chu P. B. Fernandes A. K. Claiborne E. Pihuleac Nordeen A. G. Pernet 1985 Synthesis and structureactivity relationships of novel arylfluoroquinolone antibacterial agents J. Med. Chem. 28 1558 1564
10. G. C. Crumplin 1988 Aspects of chemistry in the development of the 4-quinolone antibacterial agents Clin. Infect. Dis. [Rev Infect Dis] 10 1 9
11. T. W. C. Daniel B. F. Prabhavathi 1989 Structure-activity relationships of the fluoroquinolones Antimicrob. Chemother. 33 131 135
12. J. M. Domagala C. L. Heifetz M. P. Hutt T. F. Mich J. B. Nichols M. Solomon D. F. Worth 1988 1-Substituted 7-[3-[(ethylamino) methyl]-1- pyrrolidinyl]-6, 8-difluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure activity relationships at N1 for the quinolone antibacterials J. Med. Chem. 31 991 1001
13. A. Foroumadi S. Emami A. Hassanzadeh M. Rajaee K. Sokhanvar M. H. Moshafi A. Shafiee 2005 Synthesis and antibacterial activity of N-(5-benzylthio-1, 3, 4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1, 3, 4-thiadiazol-2-yl) piperazinyl quinolone derivatives Bioorg. Med. Chem. Lett. 15 4488 4492 (Pubitemid 41253880)
14. A. Foroumadi S. Emami S. Mansouri A. Javidnia N. Saeid-Adeli F. H. Shirazi A. Shafiee 2007 Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring Eur. J. Med. Chem. 42 985 992
15. A. Foroumadi S. Emami M. Mehni M. H. Moshafi A. Shafiee 2005 Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones Bioorg. Med. Chem. Lett. 15 4536 4539 (Pubitemid 41253889)
16. A. Foroumadi S. Mansouri Z. Kiani A. Rahmani 2003 Synthesis and in vitro antibacterial evaluation of N-[5-(5-quinolones Eur. J. Med. Chem. 38 851 854
17. V. Franklin Z. Tamara R. Carlos R. Alvaro C. Tulynan D. Yrene I. Carla M. C. Ylec L. Verónica G. Lubimar O. Jessenia F. Alberto 2008 Synthesis, primary photo-physical and antibacterial properties of naphthyl ester cinoxacin and nalidixic acid derivatives J. Photochem. Photobiol. B: Biol. 92 83 90
18. S. L. Helfand J. Werkmeister J. C. Roder 1982 Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis J. Exp. Med. 156 492 505 (Pubitemid 12041410)
19. K. Hirosato S. Fumio K. Kiyotaka T. Goro 1988 Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives J. Med. Chem. 31 221 225
20. R. Janknegt 1986 Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy Pharm Weekbl [Sci]. 8 1 21
21. G. Klopman O. T. Macina M. E. Levinson H. S. Rosenkranz 1987 Computer automated structure evaluation of quinolone antibacterial agents Antimicrob. Agents Chemother. 31 1831 1840
22. H. Koga A. Itoh S. Murayama S. Suzue T. Irikura 1980 Structure-activity relationships of antibacterial 6, 7-and 7, 8-disubstituted 1-alkyl-1, 4-dihydro-4-oxoquinoline-3-carboxylic acids J. Med. Chem. 23 1358 1363
23. G. Y. Lesher E. J. Froelich M. D. Gruett J. H. Bailey R. P. Brundage 1962 1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents J. Med. Pharm. Chem. 5 1063 1065
24. A. M. Lester 2005 Bacterial topoisomerase inhibitors: Quinolone and pyridone antibacterial agents Chem. Rev. 105 559 592
25. Z. R. Li H. Y. Guo Z. P. Zhang 1991 Studies on pyridone carboxylic acids as anti-bacterial agents. IX. Study on prodrugs of some pyridone carboxylic acids Yao Xue Xue Bao. 26 111 6
26. M. T. Mascellino S. Farinelli F. Iegri E. Iona C. De Simone 1998 Antimicrobial activity of fluoroquinolones and other antibiotics on 1, 116 clinical Gram-positive and Gramnegative isolates Drugs Expert. Clin. Res. 24 139 151
27. J. H. Paton D. S. Reeves 1988 Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use Drugs. 36 193 228
28. S. Pfeiffer A. Lass K. Schmidt B. Mayer 2001 Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite FASEB J. 15 2355 64
29. C. C. Sanders 1988 Ciprofloxacin: in vitro activity, mechanism of action, and resistance Rev Infect Dis. 10 516 527
30. L. L. Shen L. A. Mitscher P. N. Sharma T. J. O'Donnell D. W. T. Chu C. S. Cooper T. Rosen A. G. Pernet 1989 Mechanism of inhibition of DNA gyrase by quinolone antibacterials: A cooperative drug-DNA binding model Biochemistry. 28 3886 3894
31. C. Sissi M. Palumbo 2003 The quinolone family: From antibacterial to anticancer agents Curr. Med. Chem.-Anti-Cancer Agents. 3 439 450
32. S. C. Tauber R. Nau 2008 Immunomodulatory properties of antibiotics Curr. Mol. Pharmacol. 1 68 79
33. Z. B. Tomišic N. Kujundžic M. B. Krajacic A. Višnjevac B. Kojic-Prodic 2002 Molecular structures of new ciprofloxacin derivatives J. Mol. Struct. 611 73 81
34. J. Turnidge 1999 Pharmacokinetics and pharmacodynamics of fluoroquinolones Drugs. 58 29 36
35. P. Wiik P. K. Opstad A. Boyum 1996 Granulocyte chemiluminescence response to serum opsonized zymosan particlesex vivo during long-term strenuous exercise, energy and sleep deprivation in humans Eur. J. Appl. Physiol. 73 251 258
36. M. J. Wood 1989 Tissue penetration and clinical efficacy of enoxacin in respiratory tract infections Clin. Pharmacokinet. 16 38 45